Relationship of Pax6 activity levels to the extent of eye development in the mouse, Mus musculus

Jack Favor1, Christian Johannes Gloeckner, Angelika Neuhäuser-Klaus

  • 1Institute of Human Genetics, Helmholtz Zentrum München, German Research Center for Environmental Health, D-85764 Neuherberg, Germany. favor@helmholtz-muenchen.de

Genetics
|June 20, 2008
PubMed

Insights

This study introduces a new mouse Pax6 hypomorph allele, revealing that reduced Pax6 activity progressively impairs eye development. Specific thresholds in Pax6 levels dictate shifts from complete to rudimentary or terminated eye formation.

Area of Science:

  • Developmental Biology
  • Genetics
  • Molecular Biology

Background:

  • Pax6 is a crucial transcription factor for eye development.
  • Understanding Pax6's dosage sensitivity is vital for developmental studies.

Purpose of the Study:

  • To investigate the impact of varying Pax6 activity levels on mouse eye development.
  • To characterize a novel hypomorphic Pax6 allele, Pax6(132-14Neu).

Main Methods:

  • Generated and analyzed mice with a range of Pax6 activity levels (0-100%).
  • Utilized a missense mutation (Phe272Ile) in the Pax6 homeodomain.
  • Assessed DNA binding activity and reporter gene activation.

Main Results:

  • Reduced Pax6 activity leads to a progressive decrease in eye development.
  • Two critical thresholds of Pax6 activity were identified, defining distinct eye development outcomes.
  • The surface ectoderm is more sensitive to decreased Pax6 levels than the optic vesicle.

Conclusions:

  • Pax6 exhibits critical dosage-dependent roles in eye morphogenesis.
  • The Pax6(132-14Neu) allele provides a tool to study these dose-dependent effects.
  • Differential sensitivity of ocular tissues to Pax6 levels highlights regulatory complexity.

Related Concept Videos